Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

868 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Development and Assessment of a New Oral Selenium Fast-disintegrating Tablets].
Akagaki K, Kadota A, Ishida T, Sagawa T, Kagaya Y, Kawada K, Tamura N, Shiraishi H, Jobu K, Yoshioka S, Yamamoto M, Fujieda M, Miyamura M. Akagaki K, et al. Among authors: shiraishi h. Yakugaku Zasshi. 2023;143(12):1039-1046. doi: 10.1248/yakushi.23-00101. Yakugaku Zasshi. 2023. PMID: 38044109 Free article. Japanese.
Ginger Orally Disintegrating Tablets to Improve Swallowing in Older People.
Hirata A, Funato H, Nakai M, Iizuka M, Abe N, Yagi Y, Shiraishi H, Jobu K, Yokota J, Hirose K, Hyodo M, Miyamura M. Hirata A, et al. Among authors: shiraishi h. Biol Pharm Bull. 2016;39(7):1107-11. doi: 10.1248/bpb.b15-01045. Biol Pharm Bull. 2016. PMID: 27374286 Free article. Clinical Trial.
Bangle (Zingiber purpureum) Improves Spatial Learning, Reduces Deficits in Memory, and Promotes Neurogenesis in the Dentate Gyrus of Senescence-Accelerated Mouse P8.
Nakai M, Iizuka M, Matsui N, Hosogi K, Imai A, Abe N, Shiraishi H, Hirata A, Yagi Y, Jobu K, Yokota J, Kato E, Hosoda S, Yoshioka S, Harada K, Kubo M, Fukuyama Y, Miyamura M. Nakai M, et al. Among authors: shiraishi h. J Med Food. 2016 May;19(5):435-41. doi: 10.1089/jmf.2015.3562. Epub 2016 Feb 1. J Med Food. 2016. PMID: 26829513
Correction to: Severe hypoglycemia caused by a small dose of repaglinide and concurrent use of nilotinib and febuxostat in a patient with type 2 diabetes.
Komatsu H, Enomoto M, Shiraishi H, Morita Y, Hashimoto D, Nakayama S, Funakoshi S, Hirano S, Terada Y, Miyamura M, Fujimoto S. Komatsu H, et al. Among authors: shiraishi h. Diabetol Int. 2020 Apr 23;11(4):393. doi: 10.1007/s13340-020-00436-8. eCollection 2020 Oct. Diabetol Int. 2020. PMID: 33090124 Free PMC article.
Severe hypoglycemia caused by a small dose of repaglinide and concurrent use of nilotinib and febuxostat in a patient with type 2 diabetes.
Komatsu H, Enomoto M, Shiraishi H, Morita Y, Hashimoto D, Nakayama S, Funakoshi S, Hirano S, Terada Y, Miyamura M, Fujimoto S. Komatsu H, et al. Among authors: shiraishi h. Diabetol Int. 2020 Apr 8;11(4):388-392. doi: 10.1007/s13340-020-00434-w. eCollection 2020 Oct. Diabetol Int. 2020. PMID: 33088647 Free PMC article.
868 results